幽门螺杆菌感染处理共识解读及实施意见

2016-11-30 安徽医学.2016,37(11):1319-1323.

2014年1月31至2月1日在日本京都召开了关于幽门螺杆菌(Hp)胃炎的京都全球共识会议,京都共识意见引起国内外学者的高度重视”。根除HP可最大获益京都全球共识给HP治疗带来机遇和挑战,一方面需要重新重视根除HP的意义,增加治疗获益人群,预防胃癌发生;另一方面我国存在人口众多,感染率高,抗菌药物耐药率高,全面根除会增加社会经济负担;而且我国医生人数多,知识更新慢,对感染是否治疗,治疗方案及根除治疗

中文标题:

幽门螺杆菌感染处理共识解读及实施意见

发布机构:

发布日期:

2016-11-30

简要介绍:

2014年1月31至2月1日在日本京都召开了关于幽门螺杆菌(Hp)胃炎的京都全球共识会议,京都共识意见引起国内外学者的高度重视”。根除HP可最大获益京都全球共识给HP治疗带来机遇和挑战,一方面需要重新重视根除HP的意义,增加治疗获益人群,预防胃癌发生;另一方面我国存在人口众多,感染率高,抗菌药物耐药率高,全面根除会增加社会经济负担;而且我国医生人数多,知识更新慢,对感染是否治疗,治疗方案及根除治疗后随访意见不一本文根据我国第四次全国幽门螺杆菌感染处理共识意见及京都全球共识报告,结合近几年来我省在HP感染处理方面遇到的问题及相关研究提出实施意见,为规范我省HP的检测和规范化治疗随访方案提供参考。安徽医科大学消化病学系 张磊 许建明



拓展指南:幽门螺杆菌相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=幽门螺杆菌感染处理共识解读及实施意见)] GetToolGuiderByIdResponse(projectId=1, id=d20c31c001a52073, title=幽门螺杆菌感染处理共识解读及实施意见, enTitle=, guiderFrom=安徽医学.2016,37(11):1319-1323., authorId=null, author=, summary=2014年1月31至2月1日在日本京都召开了关于幽门螺杆菌(Hp)胃炎的京都全球共识会议,京都共识意见引起国内外学者的高度重视”。根除HP可最大获益京都全球共识给HP治疗带来机遇和挑战,一方面需要重新重视根除HP的意义,增加治疗获益人群,预防胃癌发生;另一方面我国存在人口众多,感染率高,抗菌药物耐药率高,全面根除会增加社会经济负担;而且我国医生人数多,知识更新慢,对感染是否治疗,治疗方案及根除治疗, cover=, journalId=null, articlesId=null, associationId=null, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Wed Nov 30 00:00:00 CST 2016, originalUrl=, linkOutUrl=, content=2014年1月31至2月1日在日本京都召开了关于幽门螺杆菌(Hp)胃炎的京都全球共识会议,京都共识意见引起国内外学者的高度重视”。根除HP可最大获益京都全球共识给HP治疗带来机遇和挑战,一方面需要重新重视根除HP的意义,增加治疗获益人群,预防胃癌发生;另一方面我国存在人口众多,感染率高,抗菌药物耐药率高,全面根除会增加社会经济负担;而且我国医生人数多,知识更新慢,对感染是否治疗,治疗方案及根除治疗后随访意见不一本文根据我国第四次全国幽门螺杆菌感染处理共识意见及京都全球共识报告,结合近几年来我省在HP感染处理方面遇到的问题及相关研究提出实施意见,为规范我省HP的检测和规范化治疗随访方案提供参考。安徽医科大学消化病学系 张磊 许建明<br> <br> <br> <br> 拓展指南:<strong>与<font color=red>幽门螺杆菌</font>相关指南:</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=2c2e01c001a43887" title="2017 ESPGHAN/NASPGHAN指南:儿童和青少年幽门螺杆菌感染的管理" target=_blank>2017 ESPGHAN/NASPGHAN指南:儿童和青少年幽门螺杆菌感染的管理</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=f6c4e1c001363058" title="2017 ACG临床指南:幽门螺杆菌感染的治疗" target=_blank>2017 ACG临床指南:幽门螺杆菌感染的治疗</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=5e7791c0011ea239" title="儿童幽门螺杆菌感染诊治专家共识2015" target=_blank>儿童幽门螺杆菌感染诊治专家共识2015</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=019421c00093e9b0" title="2012 第四次全国幽门螺杆菌感染处理共识报告" target=_blank>2012 第四次全国幽门螺杆菌感染处理共识报告</a></li> 更多信息请点击:<a href="http://www.medsci.cn/guideline/list.do?q=%E5%B9%BD%E9%97%A8%E8%9E%BA%E6%9D%86%E8%8F%8C" target=_blank>有关幽门螺杆菌更多指南</a></ul>, tagList=[TagDto(tagId=802, tagName=幽门螺杆菌), TagDto(tagId=846, tagName=感染), TagDto(tagId=22495, tagName=处理), TagDto(tagId=265, tagName=共识), TagDto(tagId=1818, tagName=解读), TagDto(tagId=49339, tagName=实施), TagDto(tagId=30498, tagName=意见)], categoryList=[CategoryDto(categoryId=4, categoryName=消化, tenant=100), CategoryDto(categoryId=34, categoryName=全科医学, tenant=100), CategoryDto(categoryId=35, categoryName=预防医学, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4604, appHits=938, showAppHits=3, pcHits=2406, showPcHits=1709, likes=130, shares=52, comments=10, approvalStatus=1, publishedTime=Fri Jun 09 10:28:35 CST 2017, publishedTimeString=2016-11-30, pcVisible=1, appVisible=1, editorId=5295982, editor=yanqin, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=yanqin, createdTime=Fri Jun 09 10:28:35 CST 2017, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 22:35:52 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=幽门螺杆菌感染处理共识解读及实施意见)])
幽门螺杆菌感染处理共识解读及实施意见
下载请点击:
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1060859, encodeId=8e5310608596b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f23b5634476, createdName=ms7000001559278818, createdTime=Fri Oct 15 21:24:33 CST 2021, time=2021-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011811, encodeId=cac610118113e, content=很好很好,很有指导意义,谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210826/4efbb9b98f33443883d248f33ce589ec/aa688c25ae724019bd016e07c59c78aa.jpg, createdBy=19505586142, createdName=影尘, createdTime=Thu Aug 26 20:38:17 CST 2021, time=2021-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978879, encodeId=d3959e8879e9, content=好棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51162194974, createdName=yxh4519, createdTime=Fri Jul 02 08:19:49 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954236, encodeId=9a5195423656, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=49d85477395, createdName=ms5000000129804130, createdTime=Tue Apr 06 16:30:49 CST 2021, time=2021-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902841, encodeId=56bd9028410a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/13/9e868433697f9337bc9c6b44718fa935.jpg, createdBy=e0062060044, createdName=公冶花, createdTime=Fri Nov 27 15:34:56 CST 2020, time=2020-11-27, status=1, ipAttribution=)]
    2021-10-15 ms7000001559278818

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1060859, encodeId=8e5310608596b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f23b5634476, createdName=ms7000001559278818, createdTime=Fri Oct 15 21:24:33 CST 2021, time=2021-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011811, encodeId=cac610118113e, content=很好很好,很有指导意义,谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210826/4efbb9b98f33443883d248f33ce589ec/aa688c25ae724019bd016e07c59c78aa.jpg, createdBy=19505586142, createdName=影尘, createdTime=Thu Aug 26 20:38:17 CST 2021, time=2021-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978879, encodeId=d3959e8879e9, content=好棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51162194974, createdName=yxh4519, createdTime=Fri Jul 02 08:19:49 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954236, encodeId=9a5195423656, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=49d85477395, createdName=ms5000000129804130, createdTime=Tue Apr 06 16:30:49 CST 2021, time=2021-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902841, encodeId=56bd9028410a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/13/9e868433697f9337bc9c6b44718fa935.jpg, createdBy=e0062060044, createdName=公冶花, createdTime=Fri Nov 27 15:34:56 CST 2020, time=2020-11-27, status=1, ipAttribution=)]
    2021-08-26 影尘

    很好很好,很有指导意义,谢谢

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1060859, encodeId=8e5310608596b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f23b5634476, createdName=ms7000001559278818, createdTime=Fri Oct 15 21:24:33 CST 2021, time=2021-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011811, encodeId=cac610118113e, content=很好很好,很有指导意义,谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210826/4efbb9b98f33443883d248f33ce589ec/aa688c25ae724019bd016e07c59c78aa.jpg, createdBy=19505586142, createdName=影尘, createdTime=Thu Aug 26 20:38:17 CST 2021, time=2021-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978879, encodeId=d3959e8879e9, content=好棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51162194974, createdName=yxh4519, createdTime=Fri Jul 02 08:19:49 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954236, encodeId=9a5195423656, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=49d85477395, createdName=ms5000000129804130, createdTime=Tue Apr 06 16:30:49 CST 2021, time=2021-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902841, encodeId=56bd9028410a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/13/9e868433697f9337bc9c6b44718fa935.jpg, createdBy=e0062060044, createdName=公冶花, createdTime=Fri Nov 27 15:34:56 CST 2020, time=2020-11-27, status=1, ipAttribution=)]
    2021-07-02 yxh4519

    好棒

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1060859, encodeId=8e5310608596b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f23b5634476, createdName=ms7000001559278818, createdTime=Fri Oct 15 21:24:33 CST 2021, time=2021-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011811, encodeId=cac610118113e, content=很好很好,很有指导意义,谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210826/4efbb9b98f33443883d248f33ce589ec/aa688c25ae724019bd016e07c59c78aa.jpg, createdBy=19505586142, createdName=影尘, createdTime=Thu Aug 26 20:38:17 CST 2021, time=2021-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978879, encodeId=d3959e8879e9, content=好棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51162194974, createdName=yxh4519, createdTime=Fri Jul 02 08:19:49 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954236, encodeId=9a5195423656, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=49d85477395, createdName=ms5000000129804130, createdTime=Tue Apr 06 16:30:49 CST 2021, time=2021-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902841, encodeId=56bd9028410a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/13/9e868433697f9337bc9c6b44718fa935.jpg, createdBy=e0062060044, createdName=公冶花, createdTime=Fri Nov 27 15:34:56 CST 2020, time=2020-11-27, status=1, ipAttribution=)]
    2021-04-06 ms5000000129804130

    学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1060859, encodeId=8e5310608596b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f23b5634476, createdName=ms7000001559278818, createdTime=Fri Oct 15 21:24:33 CST 2021, time=2021-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011811, encodeId=cac610118113e, content=很好很好,很有指导意义,谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210826/4efbb9b98f33443883d248f33ce589ec/aa688c25ae724019bd016e07c59c78aa.jpg, createdBy=19505586142, createdName=影尘, createdTime=Thu Aug 26 20:38:17 CST 2021, time=2021-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978879, encodeId=d3959e8879e9, content=好棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51162194974, createdName=yxh4519, createdTime=Fri Jul 02 08:19:49 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954236, encodeId=9a5195423656, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=49d85477395, createdName=ms5000000129804130, createdTime=Tue Apr 06 16:30:49 CST 2021, time=2021-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902841, encodeId=56bd9028410a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/13/9e868433697f9337bc9c6b44718fa935.jpg, createdBy=e0062060044, createdName=公冶花, createdTime=Fri Nov 27 15:34:56 CST 2020, time=2020-11-27, status=1, ipAttribution=)]
    2020-11-27 公冶花

    学习

    0